General Information of Drug Transporter (DT)
DT ID DTD0333 Transporter Info
Gene Name SLC38A6
Transporter Name Probable sodium-coupled neutral amino acid transporter 6
Gene ID
145389
UniProt ID
Q8IZM9
Post-Translational Modification of This DT
Overview of SLC38A6 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-N-glycosylation X-Phosphorylation X: Amino Acid

Acetylation

  Methionine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A6 [1]

Role of PTM

Potential impacts

Modified Residue

Methionine

Modified Location

1

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC38A6 Methionine 1 has the potential to affect its expression or activity.

N-glycosylation

  Asparagine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A6 [2]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

233

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC38A6 Asparagine 233 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A6 [2]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

283

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC38A6 Asparagine 283 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A6 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

4

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A6 Serine 4 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A6 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

7

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A6 Serine 7 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC38A6 [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

299

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A6 Serine 299 has the potential to affect its expression or activity.

  Threonine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A6 [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

306

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A6 Threonine 306 has the potential to affect its expression or activity.

  Tyrosine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC38A6 [6]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

304

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A6 Tyrosine 304 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC38A6 [7]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

322

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC38A6 Tyrosine 322 has the potential to affect its expression or activity.
References
1 Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3.
2 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S38A6_HUMAN)
3 Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res. 2013 Jan 4;12(1):260-71.
4 UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
5 A mutation in IFT43 causes non-syndromic recessive retinal degeneration. Hum Mol Genet. 2017 Dec 1;26(23):4741-4751.
6 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.
7 A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.